CCR5 stimulation with natural ligands, such as RANTES, classically induces short-term internalization with transient activation of β-arrestins and rapidly recycling on the cell surface. Here we discovered that, in T cells, natural CCR5 antibodies induce a CCR5-negative phenotype with the involvement of β-arrestin2, which leads to the formation of a stable CCR5 signalosome with both β-arrestin2 and ERK1. The activation of β-arrestin2 is necessary to CCR5 signaling for the signalosome formation and stabilization. When all stimuli were washed out, β-arrestin1 silencing favors the activity of β-arrestin2 for the CCR5 signalosome retention. Interestingly, CCR5 turn from Class A trafficking pattern, normally used for its internalization with natural modulating molecules (i.e. RANTES), into a long lasting Class B type specifically induced by stimulation with natural anti-CCR5 antibodies. This new CCR5 pathway is relevant not only to study in depth the molecular basis of all pathologies where CCR5 is involved but also to generate new antidody-based therapeutics

Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5

PENNISI, ROSA MARIA;SCIORTINO, Maria Teresa
Penultimo
;
2016-01-01

Abstract

CCR5 stimulation with natural ligands, such as RANTES, classically induces short-term internalization with transient activation of β-arrestins and rapidly recycling on the cell surface. Here we discovered that, in T cells, natural CCR5 antibodies induce a CCR5-negative phenotype with the involvement of β-arrestin2, which leads to the formation of a stable CCR5 signalosome with both β-arrestin2 and ERK1. The activation of β-arrestin2 is necessary to CCR5 signaling for the signalosome formation and stabilization. When all stimuli were washed out, β-arrestin1 silencing favors the activity of β-arrestin2 for the CCR5 signalosome retention. Interestingly, CCR5 turn from Class A trafficking pattern, normally used for its internalization with natural modulating molecules (i.e. RANTES), into a long lasting Class B type specifically induced by stimulation with natural anti-CCR5 antibodies. This new CCR5 pathway is relevant not only to study in depth the molecular basis of all pathologies where CCR5 is involved but also to generate new antidody-based therapeutics
2016
Inglese
ELETTRONICO
Nature Publishing Group
6
Article number - 39382
1
13
13
https://www.nature.com/articles/srep39382
Internazionale
Esperti anonimi
CCR5, NATURAL ANTIBODIES, B-ARRESTIN, PROTEIN-COUPLED RECEPTOR, AGONIST-INDUCED ENDOCYTOSIS, BETA-ARRESTIN INTERACTION, CCR5-REACTIVE ANTIBODIES, REGULATED KINASES, BREAST-CANCER, HIV-INFECTION, CELL-SURFACE, TRAFFICKING, ACTIVATION
info:eu-repo/semantics/article
Venuti, A; Pastori, C; Pennisi, Rosa Maria; Riva, A; Sciortino, Maria Teresa; Lopalco, L.
14.a Contributo in Rivista::14.a.1 Articolo su rivista
6
262
open
File in questo prodotto:
File Dimensione Formato  
VENUTI ET AL-2016.pdf

accesso aperto

Descrizione: ARTICOLO PRINCIAPLE
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 2.07 MB
Formato Adobe PDF
2.07 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3108720
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact